Safety and tolerability of omalizumab in patients with chronic idiopathic/spontaneous urticaria: Results from the OPTIMA study

被引：0

作者：

Sussman, Gordon ^{[1
]}

Hebert, Jacques ^{[2
]}

Gooderham, Melinda ^{[3
,4
]}

Gulliver, Wayne ^{[5
]}

Lynde, Charles W. ^{[6
]}

Papp, Kim A. ^{[7
]}

Yang, William H. ^{[8
]}

de Takacsy, Frederica ^{[9
]}

Chambenoit, Olivier ^{[9
]}

Rihakova, Lenka ^{[9
]}

机构：

[1] Univ Toronto, Dept Med, Toronto, ON, Canada

[2] CHU Laval, Dept Med, Laval, PQ, Canada

[3] SKiN Ctr Dermatol & Prob Med Res, Peterborough, ON, Canada

[4] Queens Univ, Kingston, ON, Canada

[5] Mem Univ Newfoundland, Fac Med, St John, NF, Canada

[6] Lynde Inst Dermatol & Prob Med Res, Markham, ON, Canada

[7] Ottawa Allergy Res Corp, Ottawa, ON, Canada

[8] Univ Ottawa, Med Sch, Ottawa, ON, Canada

[9] Novartis Pharmaceut Canada, Dorval, PQ, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

6221

引用

页码：AB250 / AB250

页数：1